Insulet Corporation Shares Decline Amid Broader Medtech Sector Weakness
In Q2 2026, Insulet Corporation (PODD) underperformed due to broader weaknesses in the medical technology sector. The company's shares closed at $161.28 on July 10, with a one-month return of 8.87% and a significant decline of 44.77% over the past year.
Tickers: $PODD
Topics: medtech sector SMID cap growth strategy stock performance